Marqeta Inc (MQ) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available. While the company has shown some positive revenue growth, the financial performance, technical indicators, and lack of strong positive catalysts suggest a cautious approach. Holding or waiting for more favorable conditions is recommended.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a downward trend. The stock is currently trading near its resistance level (R1: 4.174), which could limit further upside in the short term.

The company reported a 26.75% YoY increase in revenue in Q4 2025, showing growth in its core business. Additionally, the MACD indicates some positive momentum.
Hedge funds are selling the stock, with a 160.97% increase in selling activity last quarter. Insider trading trends are neutral, and there are no recent congress trading data or endorsements from influential figures. News of a potential investigation into fiduciary breaches by the company's directors could weigh on investor sentiment. Analyst ratings have been downgraded, and price targets have been lowered due to concerns about growth deceleration and 'noisy results.'
In Q4 2025, revenue increased by 26.75% YoY to $172.1M. However, net income dropped significantly by 94.86% YoY to -$1.39M, and EPS fell to 0, down 100% YoY. Gross margin also declined by 4.82% YoY to 64.97%. These metrics indicate that while the company is growing revenue, profitability and efficiency are deteriorating.
Analysts have recently lowered their price targets on MQ, citing concerns about growth deceleration and timing shifts in client renewals. UBS, Morgan Stanley, and JPMorgan have all reduced their targets, with UBS and Morgan Stanley maintaining Neutral and Equal Weight ratings, respectively, while JPMorgan remains Overweight but cautious.